Nl-Fr

View abstract

This abstract is assigned to session Free Paper Session VI: Immunology
Presentation preference Oral presentation
TitleEffects of VLA-4 Integrin Inhibitor on Leucocyte Subset Migration in Experimental Autoimmune Uveitis
Accept poster if oral is not possible ?Yes
PurposeVLA-4 integrin primarily affects leukocyte adhesion and trafficking. This study investigated its role in experimental autoimmune uveitis (EAU).
MethodsInterphotoreceptor retinoid binding protein induced EAU mice model was used. Topical VLA-4 inhibitor (GW559090) (10mg/ml and 30mg/ml) was given preventively and therapeutically. Clinical severity was evaluated at peak disease. T cell subsets within the eye were investigated by immunohistochemistry and immunofluorescence staining. Sub-populations of leucocytes in blood, eye and lymph nodes were analysed with flow cytometry.
Resultsopical GW559090 reduced EAU severity (P < 0.01) therapeutically and preventively, by reducing CD45+ leucocytes in the retinal tissues (P < 0.05), but not affecting retinal structure. The Th17 cells were reduced (each P ≤ 0.001), and the Th1 cells increased (each P ≤ 0.02) only locally. CD11b+CD64+ monocytes increased in the eye by GW559090 treatment. A decrease in CD11b+ dendritic cells was observed locally and systemically (each P ≤ 0.001).
ConclusionVLA-4 integrin inhibitor may exert a modulatory effect in EAU by selectively blocking Th17 cell migration across the blood-retinal barrier without affecting systemic T cell subsets. VLA-4 integrin-directed inhibition could be clinically relevant in Th17-dominant cases of uveitis.
Conflict of interestNo
Author 1
Last nameCHEN
Initials of first name(s)YH
DepartmentUCL institute of Ophthalmology, University College London
CityLondon
CountryUnited Kingdom
Author 2
Last nameEskandarpour
Initials of first name(s)M
DepartmentUCL institute of Ophthalmology, University College London
CityLondon
CountryUnited Kingdom
Author 3
Last nameLightman
Initials of first name(s)Sue
DepartmentMoorfields Eye Hospital, London, United Kingdom.
CityLondon
CountryUnited Kingdom
Author 4
Last nameCalder
Initials of first name(s)V
DepartmentUCL institute of Ophthalmology, University College London
CityLondon
CountryUnited Kingdom